ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements
TAKE Limited has submitted its Annual Report for the financial year 2025-26 as per SEBI regulations. The filing includes audited financial statements and relevant corporate reports.
TAKE Limited will hold its 25th Annual General Meeting on September 29, 2026, via video conferencing. The meeting agenda includes the adoption of financial statements.
TAKE Limited has re-appointed Parmeshvar Dhangare as a Non-Executive Non-Independent Director and appointed M/s. A. Raghavendra Rao & Associates as Statutory Auditor.
Take Limited has appointed M/s. Tejas Nadkarni & Associates as Internal Auditor. The appointment is effective for a 12-month term.
TAKE Limited appointed M/s. Tejas Nadkarni & Associates as Internal Auditor for FY 2025-26. This announcement follows the board meeting held on September 1, 2026.
TAKE Limited shareholders approved the appointment of Mr. Sunil Patra as Managing Director via postal ballot. The resolution was passed with a requisite majority on August 14, 2026.
TAKE Limited reported Q1 FY27 consolidated revenue of ₹30.37 Crore and a net profit of ₹1.06 Crore, alongside a strategic entry into the longevity market.
TAKE Ltd reported revenue from operations of ₹30.4 Cr and net profit of ₹1.1 Cr for Q1 FY27.
Take Solutions Limited is changing its corporate name to TAKE Limited, effective August 12, 2026.
TAKE Limited has scheduled a board meeting for August 11, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Take Solutions Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory disclosure under SEBI LODR regulations.
TAKE Limited issued a Postal Ballot notice for the appointment of Mr. Sunil Patra as Managing Director. The e-voting period runs from July 16 to August 14, 2026.
TAKE Limited approved the regularisation of Sunil Kailash Patra as Managing Director. A postal ballot process was initiated to obtain shareholder approval for the appointment.
Take Solutions Ltd clarifies procedural deficiencies in its financial results filing and resubmits the audited statements. No change in financial figures is reported.
Take Solutions Limited has changed its name to Take Limited. The company received the new Certificate of Incorporation on June 25, 2026.
TAKE Solutions Limited filed its FY2026 secretarial compliance report. It discloses ₹10.62 lakh in penalties levied by exchanges for delayed appointments and financial result submissions.
TAKE Solutions Limited appointed M/s. Hemang Satra & Associates as Secretarial Auditor for a five-year term. This follows the resignation of Mr. Ashok Ajay Kumar Bantia.
Take Solutions Limited approved the appointment of M/s. Hemang Satra & Associates as Secretarial Auditor for five years. This follows the resignation of Mr. Ashok Bantia.
Take Solutions reported FY26 consolidated total income of ₹60.87 Crore, a 495.68% YoY increase. The company achieved an operational turnaround with ₹10.85 Crore net profit.
TAKE Ltd reported revenue from operations of ₹54.2 Cr and net profit of ₹4.4 Cr for Q4 FY26.
Take Solutions reported FY26 consolidated total income of ₹60.87 Crore and net profit of ₹10.85 Crore. Strong performance marks a significant operational turnaround from the previous year.
Take Solutions Limited appointed Sunil Patra as Managing Director and CFO for a five-year term. This leadership change aims to strengthen operational and financial management.
Take Solutions appointed Mr. Sunil Patra as Managing Director and CFO for five years. This dual leadership role aims to streamline operations and financial management.
Take Solutions Limited scheduled a board meeting for May 20, 2026, to approve audited annual financial results. The trading window remains closed until 48 hours post-declaration.
TAKE Solutions approved a name change to TAKE LIMITED and appointed new statutory auditors. These changes align with corporate restructuring and strategic health technology expansion.
Take Solutions Ltd confirmed it does not meet the SEBI criteria for classification as a Large Corporate as of March 31, 2026. The company reported zero outstanding borrowings and no credit rating for the period. Consequently, the disclosure requirements for large corporates do not apply.
Take Solutions announced its strategic entry into India's longevity and anti-ageing market. The company plans to develop science-backed nutraceuticals, biohacking solutions, and digital tools for preventive healthcare. This initiative leverages Take's expertise in clinical research and life sciences to target the rapidly growing USD 67 billion global longevity market projected by 2035.
TAKE Ltd reported net profit of ₹1.1 Cr (-97.7% YoY) for Q3 FY26.
Take Solutions has launched a Rs. 5 Crore Innovation Fund to invest in AI, deep tech, and digital health startups. The fund targets the $400–500 billion Indian healthcare market, focusing on scalable technology and diagnostics. This initiative aligns with the company's strategic pivot toward high-margin, innovation-led sectors to drive long-term shareholder value.